19 results
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:10am
but not limited to any such Laws that prohibit private commercial bribery or (iv) made, offered or authorized any other bribe, unlawful rebate, payoff
10-Q
qq87qanrvu 7a9jc3k
17 May 21
Quarterly report
4:26pm
10-K
ss9mo9twgvjzn0lbkg2x
29 Mar 21
Annual report
4:26pm
424B4
d6jmz6v8y kz
3 Dec 20
Prospectus supplement with pricing info
4:48pm
S-1/A
zvq7r4br03 s4
30 Nov 20
IPO registration (amended)
6:05am
S-1
2uh2z23 yo
13 Nov 20
IPO registration
5:03pm
DRS/A
8k056b80ta6f2l5qa
3 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
l8405kzoge8skd
16 Oct 20
Draft registration statement (amended)
12:00am
DRS
eu38ds1mfnhu6
4 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next